less regional wall motion abnormality on echocardiogram (p=0.0045). As a complication heart failure (36% vs 9.3%), cardiogenic shock (16.8% vs 15.6%), atrial fibrillation (7.2% vs 0.78%), ventricular tachycardia (2.8% vs 0.5%), reinfarction (3% vs 0.78%) and death (2.4% vs 0.40%) were observed more in STEMI patients than NSTEMI respectively. Coronary angiogram shows that left anterior descending artery was the most commonly involved artery in STEMI; however, the left circumflex artery or right coronary artery was involved more commonly in NSTEMI (p<0.001).
Introduction
Acute myocardial infarction (MI) significantly contributes to mortality and morbidity in developing countries. To reduce mortality and morbidity, early clinical diagnosis of obstructive coronary artery diseases with subsequent management is necessary for all patients with chest discomfort or other symptoms suggestive of an acute coronary syndrome (ACS) 
Results
Among 464 patients, 256 were included in NSTEMI and 208 patients from STEMI group; 164(78.84%) male patients sustained acute STEMI whereas female were 44(21.15%). In NSTEMI male patients were 172(67.1%) and female were 84(32.8%).
Distribution of patients according to sex, age, cardiac risk factors are shown in Figure- 1,2,3 respectively. Compared to patients of STEMI, patients of NSTEMI were older. The incidence of cardiovascular risk factors such as hypertension, diabetes and hypercholesterolemia were higher in NSTEMI patients than patients of STEMI (P<0.05). In addition, coronary angiographic (CAG) shows that the incidence of multivessel involvement in NSTEMI patients were higher than that in STEMI patients (P<0.001). On echocardiographs, NSTEMI patients had limited regional wall-motion abnormality (p=0.0045) compared to STEMI. Coronary angiography revealed that the left anterior descending (LAD) artery was the most commonly involved in both STEMI (54.8%) and NSTEMI patients (40.6%); however, the left circumflex (LCx) artery played a more important role in NSTEMI than in STEMI patients (28.1% vs 4.7%; p<0.001). With regard to short-term outcome heart failure, cardiogenic shock, arrhythmias, re-infarction and death were more in STEMI patients and it was statistically significance ( Table-II) . 
Discussion
In this study, the mean age of STEMI and NSTEMI groups were 54.36±10.18 and 51.29±11 years respectively with an age range from 40 to 78 years. Majority of STEMI patients were found in 51 to 60 years of age but NSTEMI patients were mostly above 70 years. Burazeri et al 6 found that mean age of the study subjects with STEMI was 59.1±8.7 years in their study. In STEMI group male and female ratio was (4:1). In non STEMI group male and female ratio was (3:1.9).
In NSTE-MI patients complaints of retro sternal chest pain associated with other symptoms such as dyspnoea, nausea, abdominal pain, and syncope. However, atypical presentations are not uncommon 7 . These include stabbing chest pain, increasing dyspnoea, epigastric pain, indigestion. Atypical complaints are often observed in older patients over 75 years, in women, and in patients with diabetes, chronic kidney diseases, or dementia 8, 9 . In this study, most of NSTEMI patients presented with atypical central chest pain, abdominal pain, nausea, vomiting, sweating.
Patients who were treated with early revascularization having low (2.5%) risk for development of life-threatening arrhythmias with 80% occurring during the first 12 hours after onset of symptoms 10 . In this study, ST elevation was seen in all STEMI subjects and ST depression was observed in 53.2% subjects with NSTEMI. Arrythmia including atrial fibrillation, supraventricular tachycardia, ventricular tachycardia were 12.4.% and 2% in STEMI and NSTEMI respectively. Most common echocardiographic findings of the subjects were regional wall motion abnormalities. Majority of the STEMI patients had LV dysfunction. In this study, 5 patients died in STEMI and 1 in NSTEMI. STEMI patients had higher hospital mortality rate than NSTE-ACS (7% vs 3-5%, respectively), but at 6 months mortality rates were nearly similar in both conditions (12% and 13%, respectively) 15-17 . Long-term follow-up showed that death rates were higher among NSTE-ACS patients than with STE-ACS, with a two-fold difference at 4 years 18 .
This difference in mid-term and long-term evolution may be due to different patient profiles as NSTE-ACS patients were mostly older, having multiple co-morbidities, especially diabetes and renal failure. Similar study was also carried out in Bangladesh, the result of which was also consistent with this one 19 .
Limitations
This was a retrospective study of patients with a discharge diagnosis of STEMI or NSTEMI. In clinical practice, most of STEMI patients were managed by primary PCI who presented earlier, while NSTE-ACS patients received less coronary intervention. Patients enrolled in the study came from a single hospital. A regional, or even national, study should be undertaken before the results can be extrapolated to the general population.
Conclusion
At the end, it is evident that short term clinical outcome of STEMI is worse than NSTEMI. STEMI patients had higher mortality rate from acute complications within 6 months, whereas the mortality rate of NSTE-ACS patients were higher after 6 months. So, in clinical practice this suggests that, STEMI patients should be early revascularized to reduce mortality or morbidity. On the other hand, as most of NSTE-ACS patients are older and have multiple co-morbidities, so they should be counseled to increase medication adherence for secondary prevention of ischemic heart disease.
